Kempf V A, Bohn E, Noll A, Bielfeldt C, Autenrieth I B
Max-von-Pettenkofer-Institut für Hygiene und Mikrobiologie der Ludwig Maximilians Universität München, Germany.
Clin Exp Immunol. 1998 Sep;113(3):429-37. doi: 10.1046/j.1365-2249.1998.00659.x.
After invasion via M cells enteropathogenic Yersinia enterocolitica subsequently establish an infection at three different sites: (i) Peyer's patches (PP), (ii) mesenteric lymph nodes (MLN), and after systemic dissemination in (iii) spleen, liver and lung. In order to characterize protective properties of intestinal T cells at the different sites of Y. enterocolitica infection, PP and MLN T cells were isolated from Y. enterocolitica-infected C57B1/6 mice and Yersinia-specific T cell lines were generated. These T cells exhibited the phenotype of CD4 Th1 cells. The adoptive transfer of Yersinia-specific Th1 cells from PP and MLN conferred protection against a lethal orogastric inoculum with Y. enterocolitica as revealed by survival post-infection. However, determination of bacterial counts in infected organs revealed that the transfer of PP T cells conferred protection in spleen but not in MLN and PP, whereas the transfer of T cells from MLN reduced bacterial counts in both spleen and MLN but not in PP. To elucidate the different protection pattern we wanted to track the transferred cells in vivo. For this purpose the cells were labelled with the stable green fluorescent cell linker PKH2-GL prior to the adoptive transfer. In vivo tracking of these cells revealed that the distribution pattern of transferred T cells in spleen, MLN and PP correlated closely with the protection pattern observed after Yersinia infection. Thus, most cells were recovered from the spleen, while only few cells were recovered from MLN and PP. In keeping with these results a rapid and significant increase in interferon-gamma (IFN-gamma) production in the spleen of mice after adoptive transfer of T cell lines was observed. Taken together, the present results demonstrate that intestinal CD4 Th1 cells from PP and MLN may be involved in the defence against Y. enterocolitica at different sites of the infection, and that PKH2-GL labelling is a suitable tool to characterize T cell functions in vivo.
通过M细胞侵入后,肠道致病性小肠结肠炎耶尔森菌随后在三个不同部位建立感染:(i)派尔集合淋巴结(PP),(ii)肠系膜淋巴结(MLN),以及在全身播散后在(iii)脾脏、肝脏和肺中。为了表征小肠结肠炎耶尔森菌感染不同部位肠道T细胞的保护特性,从感染小肠结肠炎耶尔森菌的C57B1/6小鼠中分离出PP和MLN T细胞,并生成了耶尔森菌特异性T细胞系。这些T细胞表现出CD4 Th1细胞的表型。如感染后的存活情况所示,来自PP和MLN的耶尔森菌特异性Th1细胞的过继转移赋予了对小肠结肠炎耶尔森菌致死性经口接种的保护作用。然而,对感染器官中细菌数量的测定表明,PP T细胞的转移在脾脏中提供了保护,但在MLN和PP中没有,而来自MLN的T细胞转移减少了脾脏和MLN中的细菌数量,但在PP中没有。为了阐明不同的保护模式,我们想在体内追踪转移的细胞。为此,在过继转移前用稳定的绿色荧光细胞连接剂PKH2-GL标记细胞。对这些细胞的体内追踪表明,转移的T细胞在脾脏、MLN和PP中的分布模式与小肠结肠炎耶尔森菌感染后观察到的保护模式密切相关。因此,大多数细胞从脾脏中回收,而从MLN和PP中仅回收了少数细胞。与这些结果一致,在过继转移T细胞系后,观察到小鼠脾脏中干扰素-γ(IFN-γ)产生迅速且显著增加。综上所述,目前的结果表明,来自PP和MLN的肠道CD4 Th1细胞可能参与了在感染不同部位对小肠结肠炎耶尔森菌的防御,并且PKH2-GL标记是表征体内T细胞功能的合适工具。